Top 50 Health Care VC Funds & Investors in Italy (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
34 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $483k–$23M |
|
Club degli Investitori
VC Fund
|
15 | Italy, Switzerland, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, E-Commerce | $197k–$30M |
|
Sofinnova Partners
VC Fund
|
15 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Italian Angels for Growth
VC Fund
|
15 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Panakes Partners
VC Fund
|
12 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Indaco Venture Partners
VC Fund
|
10 | Italy, United Kingdom, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $3.3M–$110M |
|
Claris Ventures
VC Fund
|
9 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.1M–$23M |
|
LIFTT
VC Fund
|
9 | Italy, United Kingdom, France | Seed, Series A, Venture - Series Unknown | Biotechnology, Software, Manufacturing | $255k–$118M |
|
Innogest Capital
VC Fund
|
9 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
ENEA Tech e Biomedical
VC Fund
|
8 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
Principia SGR
VC Fund
|
8 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Vertis
VC Fund
|
6 | Italy, United States, United Kingdom | Seed, Series A | Software, Health Care, Biotechnology | $823k–$11M |
|
IH1
VC Fund
|
6 | Italy, Canada | Pre-Seed, Seed, Convertible Note | Health Care, Fitness, Wellness | $85k–$628k |
|
Lazio Innova
VC Fund
|
6 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Biotechnology | $22k–$1.9M |
|
a|impact
VC Fund
|
6 | Italy | Seed, Venture - Series Unknown, Series A | Health Care, Fashion, Wellness | $380k–$3.3M |
|
Healthware Ventures
VC Fund
|
6 | Italy, Austria, United States | Seed, Pre-Seed, Series A | Health Care, Personal Health, PaaS | $823k–$4.4M |
|
Angelini Ventures
VC Fund
|
6 | United States, Italy, Switzerland | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $3.3M–$132M |
|
P101
VC Fund
|
6 | Italy, Spain, United States | Seed, Series A | Software, E-Commerce, Information Technology | $236k–$15M |
|
Invitalia Ventures
VC Fund
|
5 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, B2B | $658k–$6.2M |
|
Embed Capital
VC Fund
|
5 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
Scientifica Venture Capital
VC Fund
|
5 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
The Techshop
VC Fund
|
5 | Italy, Portugal, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, FinTech | $322k–$120M |
|
Italian Angels for Biotech
VC Fund
|
5 | Italy | Seed, Pre-Seed | Health Care, Biotechnology, Pharmaceutical | $545k–$2M |
|
EUREKA! Venture SGR
VC Fund
|
5 | Italy | Seed, Venture - Series Unknown | Nanotechnology, Manufacturing, Electronics | $419k–$6.2M |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | E-Commerce, Biotechnology, Medical Device | $419k–$1.4M |
|
Lumen Ventures
VC Fund
|
4 | Italy, United States | Seed, Series A, Pre-Seed | Health Care, Medical, Software | $1.4M–$14M |
|
Utopia
VC Fund
|
4 | Italy | Seed, Pre-Seed | Biotechnology, Genetics, Health Care | $1.4M–$2M |
|
Opes Italia
VC Fund
|
4 | Italy, Spain | Venture - Series Unknown, Series A, Seed | E-Commerce, Leisure, Medical | $440k–$7.5M |
|
Pi Campus
VC Fund
|
4 | Italy, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, Mobile, Biotechnology | $100k–$6.4M |
|
Intesa Sanpaolo
VC Fund
|
3 | Italy, United Kingdom, United States | Debt Financing, Post-IPO Debt, Convertible Note | Energy, Manufacturing, Renewable Energy | $299k–$2.5B |
|
Andera Partners
VC Fund
|
3 | France, United States, Germany | Series B, Private Equity, Series A | Biotechnology, Health Care, Medical | $7M–$237M |
|
Club Italia Investimenti 2
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Pre-Seed | E-Commerce, Software, Mobile | $55k–$576k |
|
Alchimia Investments
VC Fund
|
3 | Italy, United Kingdom, Israel | Series A, Seed, Venture - Series Unknown | Software, Health Care, Medical | $2.2M–$40M |
|
Fondazione Social Venture Giordano dell'Amore
VC Fund
|
3 | Italy | Venture - Series Unknown, Seed, Pre-Seed | Health Care, Art, Software | $28k–$2.2M |
|
Brixia Group
VC Fund
|
3 | Italy | Seed, Venture - Series Unknown | Health Care, Wellness, Nutrition | $2.8M–$3.3M |
|
EXOR N.V.
VC Fund
|
3 | United States, Italy, France | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $320k–$60M |
|
Exor Ventures
VC Fund
|
3 | United States, Italy, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, FinTech | $320k–$50M |
|
Alecla7
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Pre-Seed, Series A | Financial Services, FinTech, Health Care | $727k–$8.2M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Azimut Libera Impresa
VC Fund
|
3 | Italy, France, Switzerland | Series A, Seed | Software, Information Technology, Food and Beverage | $1.4M–$14M |
|
CDP Equity
VC Fund
|
3 | Italy, United Kingdom | Series A, Seed, Pre-Seed | SaaS, Events, Education | $2.3M–$13M |
|
Growth Engine
VC Fund
|
2 | Italy, Mexico, United Kingdom | Seed, Secondary Market, Pre-Seed | Software, E-Commerce, Information Technology | $300k–$4.2M |
|
NovaCapital
VC Fund
|
2 | Italy, Israel, Austria | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $137k–$40M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$75M |
|
Vodafone
VC Fund
|
2 | United States, Italy, United Kingdom | Seed, Series B | Mobile, Enterprise Software, Information Technology | |
|
UniCredit
VC Fund
|
2 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt, Pre-Seed | Renewable Energy, Energy, Manufacturing | $197k–$1.4B |
|
Reale Group
VC Fund
|
2 | Italy, Spain | Seed, Series A | FinTech, Insurance, Banking | $329k–$2.1M |
|
Wolsey Ventures
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Angel, Pre-Seed | Health Care, Legal, Fashion | $220k–$12M |
|
Rancilio Cube
VC Fund
|
2 | United States, Italy, Germany | Seed, Series A, Series B | E-Commerce, Software, Financial Services | |
|
Primo Capital
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Series A, Pre-Seed | Software, Aerospace, Artificial Intelligence | $329k–$37M |
| Access all 443 VC funds in Italy Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 295
- Round size: Seed $483k–$7.7M; Series A $3.3M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 114
- Round size: Seed $197k–$8.2M; Pre-Seed $204k–$1.9M; Series A $889k–$30M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Quantum Bridge — Quantum Bridge is a pioneer in Distributed Symmetric Key Exchange (DSKE) technology. It offers quantum-safe cybersecurity products and services. Quantum-safe product and services, Quantum-safe roadmap and quantum-safe solutions implementation.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 329
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 105
- Round size: Seed $329k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana — Autonomous systems for enterprise
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $10M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 47
- Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $2.1M–$11M; Series A $6.1M–$23M; Series B $7.4M–$21M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Lever Bio — Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
- Haptena Therapeutics — Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune engineering. Our research focuses on KRAS-mutant tumors to deliver more effective and durable treatment options.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $255k–$7.6M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Capitali e competenze per accelerare l'innovazione. Attraverso fondi di investimento chiusi investiamo in startup, scaleup e PMI innovative
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $823k–$4M; Series A $1.5M–$11M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Scuter — Scuter is the smart e-scooter sharing service that makes city mobility,simple, enjoyable and sustainable. Scuter is on well on its path toward making a dent in this space.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
IH1 is company that invest in the startups created by Mamazen Startup Studio
Show more...Investment focus
- Industry: Health Care, Fitness, Wellness
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: Italy, Canada
Investor stats
- Total investments: 19
- Round size: Seed $85k–$628k; Pre-Seed $109k–$219k; Convertible Note $158k–$618k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Deeva — deeva is an online platform for booking home hairdressers.
- Pelomatto — Pelo Matto offers dog grooming services that are both comfortable and soothing for dogs.
- Balanced — Un nutrizionista online dedicato che legge il tuo diario e ti risponde ogni giorno. Piano personalizzato, supporto costante su WhatsApp. Primo colloquio gratuito.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $400k–$1.9M; Grant $22k–$121k; Pre-Seed $53k–$518k
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more...Investment focus
- Industry: Health Care, Fashion, Wellness
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Italy
Investor stats
- Total investments: 11
- Round size: Seed $380k–$1.5M; Venture - Series Unknown $418k–$3.3M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Id.Eight — D.EIGHT is a brand of eco-friendly sneakers produced from food industry waste and recycled material.
- AmaliaCare — AmaliaCare is a socially conscious company that gives a new perspective to the world of aged care. AmaliaCare are the premier digital employment agency, specializing in profiling the ideal domestic workers using cutting-edge technology for families seeking dependable assistance for loved ones who are no longer self-sufficient.
- HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
Healthware Ventures is the corporate venture capital arm of Healthware Group
Show more...Investment focus
- Industry: Health Care, Personal Health, PaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Austria, United States
Investor stats
- Total investments: 8
- Round size: Seed $823k–$4.4M; Pre-Seed $1M–$1.3M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
- 1000Farmacie — 1000Farmacie is the leading Pharmacy Marketplace in Italy. Though a network of independent Pharmacies we deliver faster!
- Newel Health — Certified digital medical devices for chronic disease, built to the standard the problem deserves.
Angelini Ventures is an investment firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Italy, Switzerland
Investor stats
- Total investments: 32
- Round size: Seed $3.3M–$13M; Series A $11M–$105M; Series B $19M–$132M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Nobi — Fall detection for the elderly at your home or in a residential care center with the smart Nobi lamp. Nobi ensures that you can be helped quickly.
- Vantis — Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
- Handspring Health — Handspring Health is an evidence-based behavioral health center that provides children and families with essential mental health treatment, counseling, and lifelong skills that empower their success. We currently provide therapy to children between the ages of 10 and 17.
P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Spain, United States
Investor stats
- Total investments: 114
- Round size: Seed $236k–$4.1M; Series A $2.1M–$15M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
- A-Cube — A-Cube API: la piattaforma globale per la Tax Compliance. Integra la fatturazione elettronica e gli obblighi fiscali in ogni ERP o e-commerce in Italia e nel mondo.
- Incapto Coffee — Incapto provides coffee solutions that combine specialty whole-bean coffee, super-automatic coffee machines, and subscription-based delivery services for consumers and businesses. The company supplies freshly roasted coffee beans sourced from multiple origins and delivers them directly to customers through recurring subscriptions, ensuringcontinuous availability and freshness. Its offering includes fully automatic coffee machines that grind and brew beans on demand, enabling users to prepare coffee without single-use capsules or manual preparation steps. The company also provides workplace coffee solutions, supplying machines, beans, and technical support for offices, hotels, and food service environments.Incapto integrates digital tools that track consumption, manage inventory, and automate replenishment, allowing customers to monitor usage and receive supplies based on demand. It also offers complementary products such as accessories, beverages, and maintenance services to support ongoing operation of its coffee systems.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, B2B
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 17
- Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 76% lead, 24% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Portugal, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $2M–$8.1M; Pre-Seed $322k–$37M; Series A $7.7M–$120M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- Mirai Robotics — Autonomy and intelligence for the seas. We're building software-defined autonomous systems and AI platforms that unify vessels, sensing, and command at sea.
Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $545k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Electronics
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 38
- Round size: Seed $419k–$4.1M; Venture - Series Unknown $2.2M–$6.2M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- BeNewtral — Il futuro delle costruzioni rispetta l'ambiente
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- BeDimensional — New Material Solution
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: E-Commerce, Biotechnology, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 14
- Round size: Seed $419k–$1.4M; Pre-Seed $734k–$1M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- AdapTronics — AdapTronics is a deep-tech startup that produces adaptive mechatronic devices to make logistics sustainable on Earth and in space. Its adaptive mechatronics technology offers an alternative based on a multifunctional electrostatic membrane that allows the gripping and manipulation of objects of any shape. In addition, it offers a thin-filmtechnology with sensor capabilities that becomes adhesive when electrically activated.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, United States
Investor stats
- Total investments: 11
- Round size: Seed $1.4M–$5.3M; Series A $5.3M–$14M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Serenis Health — Serenis Health provides video-based psychotherapy, coaching, and psychological support courses. It believes that the internet is critical to increasing access to mental health care. It makes use of data and digital tools to improve the efficacy of therapies. But, unlike other platforms, it is also a medical center, which means it is responsible forcourse quality and must meet the same standards as any polyclinic.
- AutoConnexa — Scopri AutoConnexa, l'assicurazione online per la tua auto che premia lo stile di guida. Con Drive Connexa, meglio guidi e meno paghi.
Utopia is a venture capital firm that is dedicated to life sciences.Utopia SIS is an investment company specializing in healthcare and biomedical research, promoted and owned by the Golinelli Foundation.Utopia was established with the aim of bridging this gap, through investments in high-potential start-ups operating in the Life Sciencessector.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $1.4M–$2M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Lighthouse Biotech — Lighthouse Biotech offers a liquid biopsy tool that helps to extract live and intact circulating tumor cells from a simple blood sample, to avoid repetition with altered metabolism, helping medical staff and doctors to trace and treat tumor cells in the very early stages of the disease.
Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.
Show more...Investment focus
- Industry: E-Commerce, Leisure, Medical
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Italy, Spain
Investor stats
- Total investments: 13
- Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Baluwo — Toda la ayuda para tu familia en una sola App
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
- GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Pi Campus is a startup district and a venture fund that invests in talent. We provide startups with money, mentorship and the best work environment for growth.
Show more...Investment focus
- Industry: Software, Mobile, Biotechnology
- Stage:Seed, Pre-Seed, Angel
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $125k–$6.4M; Angel $400k–$1M; Pre-Seed $100k–$1.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Loquis — La prima piattaforma per ascoltare e raccontare il mondo tramite podcast geolocalizzati
- Intron Health — Voice AI Built for How Africa Speaks Our next-generation intelligent voice model built from the ground up for AfricaUnlike Global systems retrofitted for the continent Sahara v-2 understands how Africa actually sounds Build with Sahara Try Sahara Built for African SpeechFrom Lagos Call Centers, to Hospitals in Nairobi, Boardrooms in Cape Town, and Courtrooms in
- Cyberwave — Transform your industry with AI-defined robotics. Frictionless automation that makes advanced robotics accessible to manufacturers of all sizes.
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.
Show more...Investment focus
- Industry: Energy, Manufacturing, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Convertible Note
- Geography: Italy, United Kingdom, United States
Investor stats
- Total investments: 141
- Round size: Post-IPO Debt $112M–$2.5B; Debt Financing $1.1M–$1000M; Convertible Note $299k–$2.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- ESAPRO — ESAPRO designs, constructs, and manages plants for the production of electricity from renewable sources.
- Cornaglia — Cornaglia designs, develops, and manufactures metal and plastic components for the automotive industry.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 185
- Round size: Series A $7M–$83M; Series B $14M–$85M; Private Equity $110M–$237M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Club Italia Investimenti is a Milan-based venture capital firm that assists startups in raising seed capital.
Show more...Investment focus
- Industry: E-Commerce, Software, Mobile
- Stage:Seed, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $55k–$576k; Pre-Seed $110k–$219k
- Lead/follow: 1% lead, 99% follow
- Last fund: May invest from a new fund soon — raised $5.9M in 2013
Portfolio highlights
- UNGUESS (formerly AppQuality) — UNGUESS is the crowdsourcing platform for effective testing and real insights. Take the guesswork out of your work.
- Paragraph — Paragraph turns your startup's launches, product updates, customer learnings, and founder thinking into an owned media engine your team approves.
- La Passione — High quality Italian Road and Urban cycling wear at fair prices. We use only the finest materials and sell direct to you with no middleman. Shop now!
Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Italy, United Kingdom, Israel
Investor stats
- Total investments: 21
- Round size: Seed $2.2M–$11M; Series A $4.4M–$40M; Venture - Series Unknown $5.8M–$14M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Stellar — At Stellar we bring perfect internet on the move to vehicles and passengers, leveraging the combined strength of cellular, wi-fi, and satellite networks, through AI and fully integrated solutions. We offer SaaS, data plans, and all-inclusive options for enterprise connectivity needs on the move.
FSVGDA aims at the promotion of the impact investing culture, in order to facilitate social innovation.
Show more...Investment focus
- Industry: Health Care, Art, Software
- Stage:Venture - Series Unknown, Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 20
- Round size: Seed $205k–$549k; Venture - Series Unknown $28k–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- C.NEXT — C.NEXT develops innovation projects for businesses and organizations by supporting the economy and territorial regeneration.
- Vivavoce — Il centro medico Vivavoce, Specializzato nel trattamento riabilitativo della #balbuzie. Disturbi del Linguaggio, DSA, Psicologia e Neuropsichiatria infantile.
- Way Experience — Way Experience operates in all the entertainment B2C sectors, using augmented and virtual reality technology. They also work in the B2B area by applying their technologies for customized consultancy projects in the following sectors: design, fashion, medical, events, and training.
The Brixia Group is a holding company that operated in sectors like distribution of fuel, industrial vehicles, and real estate.
Show more...Investment focus
- Industry: Health Care, Wellness, Nutrition
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $2.8M–$3.3M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.
- HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
EXOR is a holding company based in the Netherlands that the Agnelli family controls. The company has a diverse portfolio of investments in various industries, including automotive, real estate, and finance. The company is known for taking a long-term approach to its assets and has a reputation for being a patient and value-oriented investor. Thecompany's primary focus is on creating long-term value for its shareholders by actively managing and growing its portfolio of investments.EXOR's core mission is to cultivate exceptional enterprises, simultaneously nurturing opportunities for its talented workforce to flourish, make meaningful societal contributions, and yield outstanding returns for its valued investors.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Italy, France
Investor stats
- Total investments: 143
- Round size: Seed $1.8M–$18M; Pre-Seed $320k–$5.1M; Series A $9.5M–$60M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- RobCo — Easily automate the repetitive tasks in your production facility with modular industrial robots from RobCo.
- Q.ai — Q.ai provides systems designed to support high data throughput, multilingual interaction, privacy controls, and accessibility features within communication workflows. Its technology is used to enhance real-time and asynchronous interactions between users who operate across different languages and regions. Q.ai’s platform is designed to integrateinto existing applications and services, supporting organizations that require consistent communication standards across distributed teams and audiences.
- Philips — Koninklijke Philips is a technology company that provides healthcare, consumer lifestyle, and lighting products, solutions, and services. The company offers professionals with healthcare, lighting, and oral healthcare products, professional dictation, and display solutions, and innovation services. It offers consumers electronic products related tosound and vision, personal care, mother and child care, housewares, lighting, PCs and phones, and more.
Exor Ventures is the venture capital arm of Exor, one of Europe's largest diversified holding companies. Exor Ventures focuses on early and growth-stage investments in technology-driven companies across various sectors, including digital services, fintech, cybersecurity, and mobility. Exor Ventures leverages its strategic insights and globalnetwork to identify promising startups with disruptive potential and supports them through funding, mentorship, and access to its extensive resources. EXOR Seeds offers a truly different type of partnership to the select group of entrepreneurs that it backs:- As a fifth-generation family-led business, we proved that we are builders not traders;- Our permanent capital allows us to take a long-term view and put the interest of the companies We invest in first;- Our global network, across industries and geographies, is a unique advantage to entrepreneurs
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 127
- Round size: Seed $1.8M–$18M; Pre-Seed $320k–$3.2M; Series A $7M–$50M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- N5 Now — N5 has developed the way out of your complex legacy systems and into the fintech digital world, without having to change your core technology. Contact Us!
- PhaseV — PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions for fast, efficient, and accurate clinical development decisions.
- Byzantine Finance — Stake assets, secure other services, and earn more. Restake now with Byzantine Finance to become part of DeFi's next generation. Building the most secure and profitable future for staking.
Private investment firm founded by Angelomario Moratti in 2015, which mainly focuses on early-stage VC opportunities
Show more...Investment focus
- Industry: Financial Services, FinTech, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 12
- Round size: Seed $1.2M–$8.2M; Pre-Seed $727k–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tundr — Tundr combines technology with environmentally friendly mobility. TundrMove is the first sustainable mobility voucher. A winning combination for improving workplace quality of life while also redefining the concept of green mobility. The ecosystem includes a SmartCard, on which it will be possible to load mobility vouchers and a brand new App toexplore more ecological and sustainable modes of transport and estimate CO2 emissions.
- Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
- Klaris — Klaris reviews medical-device technical documentation clause by clause; every gap cites the standard with a fix. ISO/IEC 27001:2022 certified, GDPR compliant.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Azimut Libera Impresa is an investment company for both retail and institutional investors.
Show more...Investment focus
- Industry: Software, Information Technology, Food and Beverage
- Stage:Series A, Seed
- Geography: Italy, France, Switzerland
Investor stats
- Total investments: 27
- Round size: Seed $4.1M–$8.2M; Series A $1.4M–$14M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Webidoo — Scopri il Webidoo AI Operating System per il Business, il layer operativo che potenzia le imprese e guida l'innovazione tecnologica nel B2B.
- SylloTips — SylloTips is an all-in-one knowledge sharing platform that leverages artificial intelligence to optimize the circulation of skills and knowledge among all employees in a company
- UpSurgeOn — The UpSurgeOn Academy is a hi-tech sequence of virtual and physical technologies designed to support Mental and Manual training and empower cognitive and psychomotor skills of any surgeon.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: SaaS, Events, Education
- Stage:Series A, Seed, Pre-Seed
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 16
- Round size: Seed $3.3M–$13M; Series A $2.3M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Gility — Gility is a digital learning platform that collaborates with business schools and training institutions for an effective training offer. Established in 2022, it was supported by CDP Venture Capital and BPER Banca.
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Valvitalia SpA. — VALVITALIA is a leading group in the field of design, production, and overall supply of equipment and components intended for the petroleum, water, natural gas industries, and petrochemical industry as well as electrical power stations. The group works mainly with valves (core product), actuators, pipe fittings, flanges and systems for measuring,filtering, and regulating fluids and gases and with FireFighting systems. VALVITALIA was set up with the precise objective of becoming the leading Italian group able to offer such a wide range of products and to compete with the large American multinationals that have always dominated this field. This young company has extensive experience in the sector, thanks to its professional management and historical brands in the valve world that have been taken on by the Group, including: ROTOR, DELTA V.E., THEVIGNOT, VANADOUR, VITAS, TORMENE T.G.T. and TECNOFORGE. VALVITALIA has always included safety and respect for the environment and its employees among its priorities.
Growth Engine is a Venture Capital holding investing in Pre-Seed and Seed high-potential opportunities. With a current portfolio of more than 40 companies, most of them evolved in successful Scaleups, Growth Engine is a diversified asset class by sector and stage. Growth Engine Shareholders are entrepreneurs who have built companies from the groundup, collectively creating billions in value, and top executives managing companies with multi-billion-dollar valuations.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Secondary Market, Pre-Seed
- Geography: Italy, Mexico, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $329k–$4.2M; Pre-Seed $300k–$1.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- BonusX — Con l'app BonusX hai un supporto anti-burocrazia tutto l'anno. Accedi a centinaia di bonus e servizi pubblici, senza stress e code.
- CiaoDott —
- Vivaio Ventures — Vivaio Ventures partners with early-stage and creator-led consumer brands to scale food, beverage, and beauty products. We offer capital, consulting, and Made in Italy manufacturing excellence for the next CPG leaders.
NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Israel, Austria
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$40M; Pre-Seed $137k–$140k; Series A $5.5M–$22M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
- Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
- Juniper Biosciences — Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 36
- Round size: Series A $2.7M–$41M; Series B $7.4M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Vodafone is a leading technology communications company in Europe and Africa, keeping society connected and building a digital future. Find out more!
Show more...Investment focus
- Industry: Mobile, Enterprise Software, Information Technology
- Stage:Seed, Series B
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 9
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Ziggo Group — Ziggo Group is an entity formed by Liberty Global.
- FifthIngenium — FifthIngenium provides immersive experiences that elevate education, healthcare, and manufacturing through cutting-edge technology.
- AST SpaceMobile — AST SpaceMobile is building the first and only global broadband cellular network in space to operate directly with standard, unmodified mobile devices based on our extensive IP and patent portfolio. The company's team of engineers and space scientists are on a mission to eliminate the connectivity gaps faced by today's five billion mobilesubscribers and finally bring broadband to the billions who remain unconnected. The company was founded on May 31, 2017 and is headquartered in Midland, TX. The listed name for ASTS is AST SpaceMobile, Inc. Class A Common Stock.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Manufacturing
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 138
- Round size: Pre-Seed $197k–$197k; Post-IPO Debt $38M–$1.4B; Debt Financing $521k–$938M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- Ivpc Group — Ivpc Group is a renewable energy company that specializes in the development and management of wind farms and turbines.
- Mercuria — A world leading independent energy and commodity group
Reale Group Corporate Venturing is the division of the Reale Group’s Digital & Innovation area whose aim is to search for the best Italian and foreign innovative startups and invest in them, with the aim of creating industrial synergies within the Group’s companies and assisting them in their process of growth and business development. In anincreasingly aggressive market, we strongly believe that investing in startups is an essential condition to support the development and innovation of Reale Group.We particularly aim at organizations that possess a team of talents with high competence and knowledge and that prove to jump on their competitors by taking advantage of technological product and process innovation. In our scouting activity, we liaise with a network made up of the most relevant Italian and international Venture Capital players. The way we workWe make direct investments in the equity of the selected startups, thus helping their business and providing the required economic resources, always respecting their independence. To do so, we are supported by an interdisciplinary team of experts in law and finance, along with banking, insurance and technology experts with the capability to evaluate, in a quick, exhaustive and efficient way, the startups of interest, in order to secure a conscious involvement, capable of producing mutual advantages. Investments do not constitute our only method of contact with the startups world though. We are also available to consider partnerships along with services provision, in case the startups meet the requirements.
Show more...Investment focus
- Industry: FinTech, Insurance, Banking
- Stage:Seed, Series A
- Geography: Italy, Spain
Investor stats
- Total investments: 9
- Round size: Seed $329k–$2.1M; Series A $1.2M–$1.4M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Canitas — Canitas is a pet's social security. A new veterinary generation that challenges the way pets have traditionally been treated. The clinic elevates animals to the same level as humans by providing them with the necessary health care at a low cost. It strive to safeguard animals by providing them with attention, care, affection, prevention,specialized personnel, cutting-edge technology, and high-quality facilities.
- Pharmercure — Pharmercure is a marketplace that provides quick delivery of all pharmacy products, from prescription medicines to supplements, choosing between a wide range of products, allowing customers to receive the products at home.
- Yolo Tech Insurance — YOLO Group, uno dei principali operatori nel mercato insurtech italiano dei servizi assicurativi digitali, quotato in borsa sul segmento EGM.
We lead, co-lead and at times just partecipate and invest anywhere in all pre-venture and series A rounds, helping organizations become enduring businesses.Yet entrepreneurs and investors aspire to learn from each other and remain inspired.Our mission at Wolsey Ventures consists in technology startups.We believe adoption of smart, digital andhigh technologies will continue to rise in 2016 and beyond,to meet demands from consumers and pressure from the competition to perform and adapt.This demand creates many opportunities for fast-growing companies to start up and reach a global scale.
Show more...Investment focus
- Industry: Health Care, Legal, Fashion
- Stage:Series A, Angel, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 5
- Round size: Pre-Seed $220k–$235k; Series A $1.7M–$12M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- SurgiQ — SurgiQ is an AI-driven healthcare technology company optimizing hospital operations through intelligent planning and scheduling solutions. With a focus on surgical procedures, chemotherapy, and rehabilitation, SurgiQ helps hospitals streamline workflows, reduce waiting times, and maximize resource efficiency. The company's patented AItechnology ensures balanced workloads and optimal patient care while improving hospital financial performance. SurgiQ serves public and private healthcare institutions, offering a scalable, high-impact solution with measurable results. The company is growing 2x YoY and preparing for further international growth.
- Tossed — Healthy eating doesn't have to be boring with our delicious hot pots, house salads, power bowls & rainbow wraps made with fresh vegetables, lean protein & low GI carbs.
- AirHelp — AirHelp is an online legal service that helps air passengers get compensation from airlines when their flight gets canceled, delayed, or overbooked. Passengers can access the service via its official Facebook page or its mobile app available for iOS and Android devices.AirHelp takes care of all the paperwork and legal communications with theairline on behalf of the passengers and claims 25% of the compensation obtained as its service fee. The compensation amount varies between $170 to $650 based on the distance flown by the flight and the duration of the delay experienced by the passenger at the final destination.AirHelp was launched in 2013 by Greg Roodt, Henrik Zillmer, and Nicolas Michaelsen.
Cube is the investment office founded by Rancilio family
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Italy, Germany
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Convoy — Using technology and automation, the Convoy Platform seamlessly connects carriers with shipments from brokers across the nation.
- FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
- Finom — Finom is an online payment solution for entrepreneurs that makes it easy to open a business account and securely manage their finances.
Primo Capital is a venture capital firm focused on seed and early stage startups. The firm is a multi-fund investment company, with four different investment practices with dedicated funds on specialized strategies. Primo Capital invests in digital/software, new space, climate technology and healthcare.
Show more...Investment focus
- Industry: Software, Aerospace, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 98
- Round size: Seed $329k–$5.4M; Pre-Seed $1.2M–$37M; Series A $3.3M–$28M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
- Yolo Tech Insurance — YOLO Group, uno dei principali operatori nel mercato insurtech italiano dei servizi assicurativi digitali, quotato in borsa sul segmento EGM.
- Italian Artisan — Elevate your fashion brand with expert Italian clothing manufacturers | Streamline your production with Italian Artisan | Low MOQ
Health Care VC funding in Italy at a glance
Stats across 498 deals from 443 investors.
Access all 443 VC funds in Italy Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 443 VC funds investing in Italy Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!